Embryonic Stem Cells . Org

Drug company GlaxoSmithKline is setting up a US$25-million, five-year collaboration with the Harvard Stem Cell Institute in Cambridge, Massachusetts. The money will support research as well as a staff exchange programme between the two partners.

Read More

This entry was posted on Thursday, July 31st, 2008 at 4:03 am and is filed under Stem Cells. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.